Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Linking genetic variants to kidney disease via the epigenome

The largest GWAS for kidney function so far provided the starting point for integrated multi-stage annotation of genetic loci. Whole kidney and single-cell epigenomic information is crucial for translating GWAS information to the identification of causal genes and pathogenetic (and potentially targetable) cellular and molecular mechanisms of kidney disease.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Fig. 1: Translating genetic and epigenetic variations into mechanisms of kidney disease.

References

  1. Collaboration, G. B. D. C. K. D. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 395, 709–733 (2020). This paper reports the global, regional, and national burden of chronic kidney disease between 1990 and 2017.

  2. Sullivan, K. M. & Susztak, K. Unravelling the complex genetics of common kidney diseases: from variants to mechanisms. Nat. Rev. Nephrol. 16, 628–640 (2020). A Review article that presents the approaches and challenges to annotate genetic variants associated with kidney function.

    Article  Google Scholar 

  3. Sheng, X. et al. Mapping the genetic architecture of human traits to cell types in the kidney identifies mechanisms of disease and potential treatments. Nat. Genet. 53, 1322–1333 (2021). This paper reports 182 genes associated with kidney function using colocalization between GWAS and eQTL.

    CAS  Article  Google Scholar 

  4. Yao, D. W., O’Connor, L. J., Price, A. L. & Gusev, A. Quantifying genetic effects on disease mediated by assayed gene expression levels. Nat. Genet. 52, 626–633 (2020). This paper reports a quantitative method for estimation of disease heritability mediated by the cis-regulatory logic.

    CAS  Article  Google Scholar 

  5. Boix, C. A., James, B. T., Park, Y. P., Meuleman, W. & Kellis, M. Regulatory genomic circuitry of human disease loci by integrative epigenomics. Nature 590, 300–307 (2021). This paper reports a comprehensive epigenomic gene-regulatory circuitry across 833 human samples from 33 tissue categories.

    CAS  Article  Google Scholar 

Download references

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This is a summary of: Liu, H. A. et al. Epigenomic and transcriptomic analyses define core cell types, genes and targetable mechanisms for kidney disease. Nat. Genet. https://doi.org/10.1038/s41588-022-01097-w (2022).

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Linking genetic variants to kidney disease via the epigenome. Nat Genet (2022). https://doi.org/10.1038/s41588-022-01098-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/s41588-022-01098-9

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing